Albert David is currently trading at Rs. 609.85, up by 6.70 points or 1.11% from its previous closing of Rs. 603.15 on the BSE.
The scrip opened at Rs. 605.00 and has touched a high and low of Rs. 624.65 and Rs. 605.00 respectively. So far 3379 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 673.00 on 13-Aug-2021 and a 52 week low of Rs. 371.45 on 26-Mar-2021.
Last one week high and low of the scrip stood at Rs. 624.65 and Rs. 587.00 respectively. The current market cap of the company is Rs. 347.91 crore.
The promoters holding in the company stood at 61.25%, while Institutions and Non-Institutions held 3.53% and 35.22% respectively.
Albert David and Corona Remedies have entered into a strategic co-marketing agreement on October 04, 2021. The company has entered into a strategic Co-Marketing agreement to help take the ‘Placenta Products (Placentrex)’, with another brand name, to a larger and wider group of end beneficiaries.
Placentrex, the human placental extract product, is an old and well established product of Albert David. It is used by the Gynecologists for PID (Pelvic Inflammatory Disease) and by Surgeons, Physicians and other doctors for difficult to heal wounds.
Albert David (ADL), a prominent drug house, distinguished in the field of manufacturing Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms, Bulk Drugs and Disposable Syringes & Needles has its base in Kolkata, India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: